| JYSB2101129 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2021-09-13 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JXSB2300033 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.4) | Supplementary Application | 2023-03-28 | | Cilag AG;Janssen Research & Development LLC | | | view |
| JYSB2500003 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2025-01-03 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2300076 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2200057 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2022-03-28 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2101146 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2021-10-11 | | Cilag AG;Janssen-Cilag International NV | | | view |
| CXSL2400136 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2024-02-21 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JXSL2300040 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2023-02-23 | | Janssen-Cilag International NV;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JYSB2500002 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2025-01-03 | | Cilag AG;Janssen-Cilag AG | | | view |
| JXSS2200013 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2022-04-15 | | Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag International NV | | | view |
| JYSB2300079 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| CXSL2200528 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2022-10-20 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSB2200015 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2022-01-30 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2300204 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2023-12-08 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2200040 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2022-03-10 | | Cilag AG;Janssen-Cilag International NV | | | view |
| CXSL2400635 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2024-09-21 | | CSPC Megalith Biopharmaceutical Co Ltd | | | view |
| CXSL2300108 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2023-02-09 | | Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd | | | view |
| JXSS2500061 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-14 | | Johnson & Johnson;Cilag AG;Janssen-Cilag International NV | | | view |
| JXSL2200010 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.4) | Import Drug Application | 2022-01-19 | | Janssen Research & Development LLC;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JYSB2300078 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
